Recalls are not limited to pharmaceutical products. Staska Pharmaceuticals is recalling a batch of ascorbic acid injections. The problem was related to contamination concerns. No injuries have been reported, but serious health risks exist.
Contamination Concerns Trigger Recall
STASKA PHARMACEUTICALS, INC. has taken an important step toward public safety by recalling a specific batch of its Ascorbic Acid Solution for Injections. This voluntary action was taken after the discovery of glass particulates in vials, which could pose a health risk. Affected products are 500mg/mL, 50mL vials with lot number SP2400058, which are set to expire on December 31, 2024. Healthcare professionals in Bennet, NE and surrounding areas have been advised to halt the use and distribution of this batch.
If glass particles obstruct blood vessels in medical injectables, they can cause severe complications such as local irritation, swelling, or even more serious conditions like stroke or death. This recall emphasizes the importance of being diligent in monitoring pharmaceutical production and distribution. STASKA PHARMACEUTICALS has received no incident reports involving particulate matter or harm from the use of affected products.
Staska Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles https://t.co/zUgayW983o pic.twitter.com/BDgPnWBYca
— U.S. FDA Recalls (@FDArecalls) October 17, 2024
Corrective Actions and Safety Measures
The precautionary recall instructs healthcare practitioners to thoroughly inspect vials for foreign particulates before administering them. Distributed nationwide from July 31 to August 27, 2024, the recall involves notifying all involved healthcare providers and conducting an organized process for product returns and replacements.
Providers should quarantine the affected lot and coordinate with STASKA PHARMACEUTICALS on return and replacement procedures.
Consumers and healthcare professionals who have questions can contact STASKA PHARMACEUTICALS at 402-782-2207 or 888-801-1370. Adverse reactions or quality issues can also be reported to the FDA’s MedWatch program for further investigation and resolution.
Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500 mg/mL by Staska Pharmaceuticals: Recall – Due to the Presence of Glass Particles https://t.co/pwd6kUPyWA pic.twitter.com/bwiXt51kte
— US FDA MedWatch (@FDAMedWatch) October 17, 2024
Legal and Health Precautions
While no injuries have been reported, the risk of using the contaminated injection warrants serious consideration. Due to the possibility of glass contamination, the FDA has reinforced this recall.
Notably, these products are prescription-only and intended for injection by healthcare professionals, emphasizing the importance of handling with extreme caution.
As a precaution, TruLaw is providing legal services to those who may have been impacted by the contaminated product. They encourage people who have been affected to seek advice on possible compensation claims. Healthcare organizations and the general public have a shared responsibility to act quickly and mitigate the risks posed by this recall.
Sources:
- Vitamin C Supplement Sold Nationwide Recalled
- Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles
